The investigator should report all serious adverse reactions to the drug regulatory body Drug Controller General of India (DCGI), sponsor of the trial and the concerned Ethics Committee that approved the trial protocol within 24 hour of occurrence.from Moneycontrol Business News https://ift.tt/2H3fzpW
No comments:
Post a Comment